AlzeCure elect Dr Jan Lundberg as a new board member AlzeCure elect Dr Jan Lundberg as a new board member Dr Lundberg has experience in leadership position in global pharmaceutical companies, including AstraZeneca and Eli Lilly Enhanc3D Genomics appoints Hazel Jones as CEO Enhanc3D Genomics appoints Hazel Jones as CEO Hazel Jones has held previous roles in AstraZeneca and Cancer Research UK, and will drive operational change to advance disease diagnosis and treatments ERS Genomics appoints John E Milad as CEO ERS Genomics appoints John E Milad as CEO John brings more than 25 years of experience into the role, with a majority of his career being in the life sciences industry as a venture capitalist and investment banker John Patton, Head of Kindeva's Scientific Advisory Board, named winner of Charles G. Thiel award John Patton, Head of Kindeva's Scientific Advisory Board, named winner of Charles G. Thiel award RDD Conference’s Torbay Pharma strengthens leadership team to support North American growth strategy Torbay Pharma strengthens leadership team to support North American growth strategy The company has welcomed Mohammed Nazir as Chief Operating Officer (COO) and Tara Slivey as Chief Product Officer (CPO) Rentschler Biopharma appoints Patrick Cushing as VP Operations for US subsidiary Rentschler Biopharma appoints Patrick Cushing as VP Operations for US subsidiary The novel position will require Dr Cushing to manager operations at the Miford, MA facility in the US ProBioGen appoints Alfred Merz as CEO ProBioGen appoints Alfred Merz as CEO Dr Merz joins from Bayer Pharmaceuticals as CEO, focusing on developing the global reach of ProBioGen Sphere Fluidics appoints Dale Levitzke as CEO Sphere Fluidics appoints Dale Levitzke as CEO Dale Levitzke joins as Dr Frank F. Craig, current CEO and co-founder, announces his retirement Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance First senior executive appointment made following company launch to oversee strategic development of clinical programmes Ascend hires Scott Law as COO Ascend hires Scott Law as COO He will join the company to optimise Ascend's operations from his recent role at Telix Pharmaceuticals as the Senior Vice President of Global Manufacturing and Operations Amarna Therapeutics appoints Aurelia Caparrós as new Chief Business Officer Amarna Therapeutics appoints Aurelia Caparrós as new Chief Business Officer Aurellia will be reponsible for driving Amarna's growth in the Netherlands and Spain Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer Denis will be responsible for optimising global operations for the company etherna appoints Shelly West as Business Development Director, US etherna appoints Shelly West as Business Development Director, US Shelly arrives from Cellpoint Biosciences and will be in charge of expanding etherna's US customer base Wacker Chemical Corporation promotes Christoph Kowitz to President of US subsidiary Wacker Chemical Corporation promotes Christoph Kowitz to President of US subsidiary The position originally held by David Willhoit is a promotion from Christoph's six year tenure as the Head of Corporate R&D Edward Rayner appointed as as Non-Executive Director of Sphere Fluidics Edward Rayner appointed as as Non-Executive Director of Sphere Fluidics Ed’s appointment will strengthen the company’s strategic vision as it progresses ambitious plans for future growth and commercial success KBI Biopharma appoints Jean-Baptiste Agnus as Chief Business Officer KBI Biopharma appoints Jean-Baptiste Agnus as Chief Business Officer Jean-Baptiste will bring more than 20 years' experience in the biopharmaceutical industry, and will aim to build and maintain KBI's long-term partnerships